Mostrar el registro sencillo

dc.contributor.authorLiaño-Pons, Judit
dc.contributor.authorArsenian-Henriksson, Marie
dc.contributor.authorLeón Serrano, Javier 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2021-11-17T10:37:49Z
dc.date.available2021-11-17T10:37:49Z
dc.date.issued2021
dc.identifier.issn2072-6694
dc.identifier.otherSAF2017-88026-Res_ES
dc.identifier.urihttp://hdl.handle.net/10902/23049
dc.description.abstractMNT is a crucial modulator of MYC, controls several cellular functions, and is activated in most human cancers. It is the largest, most divergent, and most ubiquitously expressed protein of the MXD family. MNT was first described as a MYC antagonist and tumor suppressor. Indeed, 10% of human tumors present deletions of one MNT allele. However, some reports show that MNT functions in cooperation with MYC by maintaining cell proliferation, promoting tumor cell survival, and supporting MYC-driven tumorigenesis in cellular and animal models. Although MAX was originally considered MNT?s obligate partner, our recent findings demonstrate that MNT also works independently. MNT forms homodimers and interacts with proteins both outside and inside of the proximal MYC network. These complexes are involved in a wide array of cellular processes, from transcriptional repression via SIN3 to the modulation of metabolism through MLX as well as immunity and apoptosis via REL. In this review, we discuss the present knowledge of MNT with a special focus on its interactome, which sheds light on the complex and essential role of MNT in cell biology.es_ES
dc.description.sponsorshipJ.L.-P. was supported by a postdoctoral scholarship from the Radiumhemmet Research Funds, Stockholm. M.A.-H. was supported by grants from the Swedish Cancer Society, the Swedish Childhood Cancer Fund, the Swedish Research Council, Radiumhemmet Research Funds, and Karolinska Institutet, and J.L. was supported by grant SAF2017-88026-R from Agencia Estatal de Investigación, from the Spanish Government.es_ES
dc.format.extent16 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceCancers (Basel) . 2021 Sep 18;13(18):4682es_ES
dc.subject.otherMNTes_ES
dc.subject.otherMYCes_ES
dc.subject.otherMAXes_ES
dc.subject.otherRELes_ES
dc.subject.otherTranscriptional regulationes_ES
dc.subject.otherProliferationes_ES
dc.subject.otherCanceres_ES
dc.titleThe Multiple Faces of MNT and Its Role as a MYC Modulatores_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/cancers13184682es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/cancers13184682
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution(CC BY) license.